Market Cap 90.31M
Revenue (ttm) 266.96M
Net Income (ttm) 28.51M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 10.68%
Debt to Equity Ratio -0.20
Volume 1,822,400
Avg Vol 1,708,078
Day's Range N/A - N/A
Shares Out 115.93M
Stochastic %K 30%
Beta 1.01
Analysts Strong Sell
Price Target $5.26

Latest News on CHRS

Coherus to Participate in Upcoming Investor Conferences

May 1, 2025, 5:04 PM EDT - 5 weeks ago

Coherus to Participate in Upcoming Investor Conferences


Why Is Coherus BioSciences Stock Trading Higher On Tuesday?

Dec 3, 2024, 9:34 AM EST - 6 months ago

Why Is Coherus BioSciences Stock Trading Higher On Tuesday?


Coherus Completes Divestiture of Ophthalmology Franchise

Mar 4, 2024, 1:00 AM EST - 1 year ago

Coherus Completes Divestiture of Ophthalmology Franchise


Coherus Announces U.S. Launch of LOQTORZI™

Jan 2, 2024, 8:29 AM EST - 1 year ago

Coherus Announces U.S. Launch of LOQTORZI™